RNA结合蛋白MSI2通过LINC00667-介导的IRF6mRNA衰变控制血液瘤屏障的透性
Rui Gao1, Xuelei Ruan1, Yixue Xue1
1Department of Neurobiology, School of Life Sciences, China Medical University, Shenyang 110122, China; Key Laboratory of Neuro-oncology in Liaoning Province, Shenyang 110004, China.
The Journal of biological chemistry
|January 25, 2026
概括
穆沙希RNA结合蛋白2 (MSI2) 和LINC00667调节了质母细胞瘤的发生.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 质母细胞瘤 (GB) 中的血液瘤屏障 (BTB) 是药物输送的重要障碍.
- 越来越多的RNA结合蛋白因其在BTB调节中的作用而得到认可.
研究的目的:
- 研究MSI2,LINC00667和IRF6在调节质母细胞瘤中BTB透性的作用.
- 通过这些因素阐明了BTB调节的基础分子机制.
- 探索针对MSI2/LINC00667/IRF6途径用于质母细胞瘤治疗的治疗潜力.
主要方法:
- 在质瘤共培养内皮细胞 (GECs) 中MSI2和LINC00667表达的分析.
- 研究MSI2敲击对LINC00667稳定性和BTB透性的影响.
- 检查IRF6表达及其对BTB透性的影响.
- 通过Staufen1-介导的mRNA衰变 (SMD) 途径阐明LINC00667-介导的IRF6mRNA降解.
- 评估IRF6对紧结蛋白 (ZO-1,奥克卢丁,克劳丁-5) 的转录调节.
- 在MSI2/LINC00667/IRF6通路的调节后,对多克索鲁比 (Dox) 输送和GB细胞亡的评估.
主要成果:
- 在GEC中,MSI2和LINC00667受到上调监管,而IRF6受到下调监管.
- MSI2的淘汰降低了LINC00667的稳定性,导致BTB的透性增加.
- LINC00667促进了IRF6mRNA的降解;IRF6过度表达通过抑制紧密结合蛋白增加了BTB的透性.
- 调节MSI2,LINC00667和IRF6增强了多克索鲁比辛的递送和质母细胞细胞的亡.
结论:
- MSI2/LINC00667/IRF6通路是质母细胞瘤中BTB透性的关键调节器.
- 准这种途径为改善药物输送和治疗质母细胞瘤提供了一个有希望的策略.
相关概念视频
02:27Nonsense-mediated mRNA Decay
11.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K
02:27Nonsense-mediated mRNA Decay
3.3K
3.3K
02:36RNA Polymerase II Accessory Proteins
10.8K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.8K
02:41Chromatin Structure Regulates pre-mRNA Processing
8.1K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
8.1K
02:31Nuclear Export of mRNA
8.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.7K
02:22Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K